Aseptika’s BuddyWOTCH medical wearable receives the IoTUK Boost

Aseptika is one of just five companies to win a place on the IoTUK Boost mentoring programme, awarded “Highly Commended in Health and Social Care category”.


The Company now gains expert mentoring and support in the onward development of the BuddyWOTCHTM medical wearable, designed for those with long-term cardiovascular and respiratory conditions.

Aseptika will receive further support via Cambridge Wireless, SETsquared and IoTUK through membership of their associated networks, physical and virtual showcase opportunities, additional mentoring and support from our expert partner organisations 4YFN, Alloy, Arkessa, Breed Reply, DHACA, EAHSN, Iotic Labs, MediaTek Labs and Tradefair.

“The IoTUK Boost prize winners are commended for the clarity of their business proposition, the simplicity of their user design, the sophistication of their health and social Care technology”, said Bob Driver, CEO of CW.

Announcing the winners, Cambridge Wireless said:


Aseptika Ltd (Activ8rlives)Special Commendation for Health and Social Care Technology

Activ8rlives has developed a solution to the crippling impact of respiratory disease in the form of BuddyWOTCH, a consumer-facing, cross-over medically-certified device collecting key vital signs to accurately forewarn of respiratory failure. The device reduces avoidable hospital admissions by using apps, encrypted data, secure transmission via WiFi and cellular connection to healthcare teams.

Activ8rlives received high praise from the judges for its advanced health and social care technology, specifically the device’s accuracy in prediction and prevention. The team was commended for its rigorous clinical approach and partnering to develop a surrounding community of expertise.

Read about the other winners in the Cambridge Wireless press release here.


About Aseptika Limited (Activ8rlives):

Aseptika Limited is a healthcare company developing and marketing an integrated suite of self-monitoring devices and services under the Activ8rlives brand. We are developing integrated systems which can be used by consumers and their healthcare service providers to better self-manage long-term health conditions (LTHC) through self-monitoring.

The Company’s goal is to provide everyone with tools (and the understanding of how to apply them) so that most of us can keep healthy and well for most of the time. Self-management through self-monitoring is the motivation driving what we do.

Activ8rlives is unusual in that we are device agnostic, incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs) with a focus on respiratory disease. All data is held together and can be cross analysed in the Cloud to provide forecasts and learning for the user and clinician.

The Company gained a patent in 2013 protecting the invention of a test for biomarkers of Pseudomonas aeruginosa (PA) in the sputum of patients, which can be used to detect the on-set of an exacerbation and profile the efficacy of antibiotic treatment for each patient.

Aseptika won first place in a competition earlier in 2014 to reward the most “Promising eHealth EU SME”eHealth solution 2014developed by an early-stage European SME. The 2014 Competition was organized by TICBioMed and had the endorsement of the Health and Wellbeing Unit of DG CONNECT of the European Commission.

Aseptika was a shortlisted finalist for the Cambridge News Top Innovations 2014 and won the  AXA PPP Health Tech & You Awards. Winner of the Discovery Start-up 2014 Competition run by Cambridge Wireless and Winner of the Hunts Post Huntingdonshire Business Innovation Awards 2014. Named on Global Digital Health 100 2014 List, reflecting the importance of mobile and digital solutions.

Wearable Technology Awards 2015 shortlisted Aseptika in three categories: Best Medical Device (placed third), Best Innovation and Overall Wearable Winner.

Aseptika was granted a patent in the United States and New Zealand protecting its invention for a test for respiratory infections early in 2015.

Aseptika was short-listed as one of twenty semi-finalists for the Cisco British Innovation Gateway (BIG) Awards and was also awarded winner of the Innovation Award for BuddyWOTCH at the Hunts Post Business Awards for 2015.

The Global Digital Health 100 List for 2015 has been named Aseptika Ltd (Activ8rlives) in the list of 100 companies for the second year in a row.

For more information on Aseptika Ltd, Activ8rlives and products, please visit:

Activ8rlives,, BuddyWOTCH and EyKos are trademarks of Aseptika Ltd.


Read more

Looking for something specific?